Vectors Research Management, LLC Adaptimmune Therapeutics PLC Transaction History

Vectors Research Management, LLC

  • $330 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$1.33 - $2.28 $9,310 - $15,959
7,000 New
7,000 $12,000
Q1 2022

May 16, 2022
SELL
$1.73 - $4.06 $12,110 - $28,419
-7,000 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$3.5 - $5.68 $3,500 - $5,680
1,000 Added 16.67%
7,000 $26,000
Q3 2021

Nov 12, 2021
BUY
$3.44 - $6.37 $6,880 - $12,740
2,000 Added 50.0%
6,000 $31,000
Q2 2021

Aug 09, 2021
BUY
$3.86 - $5.78 $15,440 - $23,120
4,000 New
4,000 $17,000

Others Institutions Holding ADAP

# of Institutions
82
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $108M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email